Ophthotech Corporation (OPHT) to Release Quarterly Earnings on Monday
Ophthotech Corporation (NASDAQ:OPHT) will be issuing its quarterly earnings data before the market opens on Monday, November 6th. Analysts expect the company to announce earnings of ($0.84) per share for the quarter.
Ophthotech Corporation (OPHT) opened at 2.31 on Monday. Ophthotech Corporation has a 12-month low of $2.24 and a 12-month high of $40.34. The stock has a 50 day moving average price of $2.58 and a 200 day moving average price of $2.66. The stock’s market cap is $83.03 million.
A number of research analysts recently commented on OPHT shares. ValuEngine raised shares of Ophthotech Corporation from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Stifel Nicolaus reaffirmed a “hold” rating and issued a $4.00 price target on shares of Ophthotech Corporation in a report on Thursday, September 21st. Twelve investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $47.33.
About Ophthotech Corporation
Ophthotech Corporation is a biopharmaceutical company. The Company is engaged in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the retina, known as the macula, that may result in blindness.
Receive News & Ratings for Ophthotech Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ophthotech Corporation and related companies with MarketBeat.com's FREE daily email newsletter.